Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases

Arthritis and Rheumatology

Volumn 68, Issue 1, 2016, Pages 35-45

  Scher, Jose U ^a   Littman, Dan R ^b   Abramson, Steven B ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ADJUVANT ARTHRITIS; ANTIBODY PRODUCTION; AUTOIMMUNITY; BACTERIAL OVERGROWTH; CD4+ T LYMPHOCYTE; CROHN DISEASE; DNA SEQUENCE; GENE AMPLIFICATION; GNOTOBIOTICS; HUMAN; INTESTINE FLORA; LYMPHOCYTE DIFFERENTIATION; MICROBIAL COMMUNITY; MUCOSAL IMMUNITY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SPONDYLARTHRITIS; ULCERATIVE COLITIS; IMMUNOLOGY; JUVENILE RHEUMATOID ARTHRITIS; MICROBIOLOGY; RHEUMATIC DISEASE; SPONDYLOARTHROPATHY;

ARTHRITIS, JUVENILE; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNITY, MUCOSAL; RHEUMATIC DISEASES; SPONDYLARTHROPATHIES;

EID: 84952020166     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39259     Document Type: Review

References (98)

1. Lederberg J., Infectious history. Science 2000; 288: 287-93.
2. Koch R., An address on bacteriological research. Br Med J 1890; 2: 380-3.
3. Scher JU, Abramson SB., The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011; 7: 569-78.
4. Chervonsky AV., Influence of microbial environment on autoimmunity. Nat Immunol 2010; 11: 28-35.
5. Yurkovetskiy LA, Pickard JM, Chervonsky AV., Microbiota and autoimmunity: exploring new avenues. Cell Host Microbe 2015; 17: 548-52.
6. Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al., The NIH Human Microbiome Project. Genome Res 2009; 19: 2317-23.
7. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-14.
8. Zhao L., Genomics: the tale of our other genome. Nature 2010; 465: 879-80.
9. Littman DR, Pamer EG., Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011; 10: 311-23.
10. Round JL, Mazmanian SK., The gut microbiota shapes intestinal immune responses during health and disease [published erratum appears in Nat Rev Immunol 2009;9:600]. Nat Rev Immunol 2009; 9: 313-23.
11. Hooper LV, Macpherson AJ., Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10: 159-69.
12. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI., The Human Microbiome Project. Nature 2007; 449: 804-10.
13. Bornigen D, Morgan XC, Franzosa EA, Ren B, Xavier RJ, Garrett WS, et al., Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med 2013; 5: 65.
14. Ursell LK, Haiser HJ, van Treuren W, Garg N, Reddivari L, Vanamala J, et al., The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 2014; 146: 1470-6.
15. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R., Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-30.
16. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al., A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-4.
17. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60.
18. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al., Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338: 120-3.
19. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al., Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-85.
20. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ., Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PloS One 2008; 3: e2719.
21. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al., Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: R79.
22. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, van Treuren W, Ren B, et al., The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382-92.
23. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al., A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-54.e1.
24. Warden CC., The toxemic factor in rheumatoid arthritis. Cal State J Med 1909; 7: 299-301.
25. Moos V, Schneider T., Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 2011; 30: 1151-8.
26. Ross CB, Scott HW, Pincus T., Jejunoileal bypass arthritis. Baillieres Clin Rheumatol 1989; 3: 339-55.
27. Svartz N., The treatment of rheumatic polyarthritis with acid azo compounds. Rheumatism 1948; 4: 180-5.
28. Svartz N., The primary cause of rheumatoid arthritis is an infection-the infectious agent exists in milk. Acta Med Scand 1972; 192: 231-9.
29. Rothschild BM, Turner KR, DeLuca MA., Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama. Science 1988; 241: 1498-501.
30. Deighton CM, Gray J, Bint AJ, Walker DJ., Specificity of the proteus antibody response in rheumatoid arthritis. Ann Rheum Dis 1992; 51: 1206-7.
31. Hoffman RW, O'Sullivan FX, Schafermeyer KR, Moore TL, Roussell D, Watson-McKown R, et al., Mycoplasma infection and rheumatoid arthritis: analysis of their relationship using immunoblotting and an ultrasensitive polymerase chain reaction detection method. Arthritis Rheum 1997; 40: 1219-28.
32. Payne JB, Golub LM, Thiele GM, Mikuls TR., The link between periodontitis and rheumatoid arthritis: a periodontist's perspective. Curr Oral Health Rep 2015; 2: 20-9.
33. Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al., Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014; 66: 1090-100.
34. Dissick A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, et al., Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 2010; 81: 223-30.
35. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, et al., Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64: 3083-94.
36. De Aquino SG, Abdollahi-Roodsaz S, Koenders MI, van de Loo FA, Pruijn GJ, Marijnissen RJ, et al., Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J Immunol 2014; 192: 4103-11.
37. Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, et al., Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64: 1756-61.
38. Willis VC, Demoruelle MK, Derber LA, Chartier-Logan CJ, Parish MC, Pedraza IF, et al., Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 2013; 65: 2545-54.
39. Catrina AI, Ytterberg AJ, Reynisdottir G, Malmstrom V, Klareskog L., Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat Rev Rheumatol 2014; 10: 645-53.
40. Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, et al., Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis 2015; 74: 1772-7.
41. Sandberg ME, Bengtsson C, Klareskog L, Alfredsson L, Saevarsdottir S., Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study. Ann Rheum Dis 2015; 74: 904-7.
42. Kohashi O, Kohashi Y, Takahashi T, Ozawa A, Shigematsu N., Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats. Microbiol Immunol 1985; 29: 487-97.
43. Kohashi O, Kohashi Y, Takahashi T, Ozawa A, Shigematsu N., Suppressive effect of Escherichia coli on adjuvant-induced arthritis in germ-free rats. Arthritis Rheum 1986; 29: 547-53.
44. Breban MA, Moreau MC, Fournier C, Ducluzeau R, Kahn MF., Influence of the bacterial flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clin Exp Rheumatol 1993; 11: 61-4.
45. Caccese RG, Zimmerman JL, Carlson RP., Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflamm 1992; 1: 273-9.
46. Van den Broek MF, van Bruggen MC, Koopman JP, Hazenberg MP, van den Berg WB., Gut flora induces and maintains resistance against streptococcal cell wall-induced arthritis in F344 rats. Clin Exp Immunol 1992; 88: 313-7.
47. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, et al., Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118: 205-16.
48. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al., Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32: 815-27.
49. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-98.
50. H17 cells towards commensal bacterial antigens. Nature 2014; 510: 152-6.
51. Toivanen P, Vaahtovuo J, Eerola E., Influence of major histocompatibility complex on bacterial composition of fecal flora. Infect Immun 2001; 69: 2372-7.
52. Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray JA, et al., Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PloS One 2012; 7: e36095.
53. Eerola E, Mottonen T, Hannonen P, Luukkainen R, Kantola I, Vuori K, et al., Intestinal flora in early rheumatoid arthritis. Br J Rheumatol 1994; 33: 1030-8.
54. Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P., Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008; 35: 1500-5.
55. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al., Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2: e01202.
56. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107: 14691-6.
57. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, et al., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145: 745-57.
58. Lukens JR, Gurung P, Vogel P, Johnson GR, Carter RA, McGoldrick DJ, et al., Dietary modulation of the microbiome affects autoinflammatory disease. Nature 2014; 516: 246-9.
59. Arvikar SL, Fisher MC., Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med 2011; 4: 123-31.
60. Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L, et al., The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995; 22: 2266-72.
61. Li WQ, Han JL, Chan AT, Qureshi AA., Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis 2013; 72: 1200-5.
62. 2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112.
63. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, et al., The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359-64.
64. 2 microglobulin transgenic rats. J Clin Invest 1996; 98: 945-53.
65. Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, et al., Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum 2012; 64: 110-20.
66. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA., HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60: 2633-43.
67. 2-microglobulin affect the gut microbiota of transgenic rats. PloS One 2014; 9: e105684.
68. k) male mice. Hum Immunol 2008; 69: 845-50.
69. Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K, et al., β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum 2012; 64: 2211-22.
70. Rehaume LM, Mondot S, Aguirre de Carcer D, Velasco J, Benham H, Hasnain SZ, et al., ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol 2014; 66: 2780-92.
71. - entheseal resident T cells. Nat Med 2012; 18: 1069-76.
72. Mielants H, Veys EM, Goemaere S, Goethals K, Cuvelier C, De Vos M., Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology: a prospective study. J Rheumatol 1991; 18: 1542-51.
73. Van Praet L, van den Bosch FE, Jacques P, Carron P, Jans L, Colman R, et al., Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 2013; 72: 414-7.
74. Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, et al., Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009; 60: 955-65.
75. Ciccia F, Accardo-Palumbo A, Alessandro R, Rizzo A, Principe S, Peralta S, et al., Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum 2012; 64: 1869-78.
76. Stebbings S, Munro K, Simon MA, Tannock G, Highton J, Harmsen H, et al., Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 2002; 41: 1395-401.
77. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, et al., Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol 2015; 67: 686-91.
78. Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, et al., Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther 2014; 16: 486.
79. Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al., Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015; 67: 128-39.
80. Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, et al., Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015; 160: 447-60.
81. Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, et al., Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014; 158: 1000-10.
82. Arvonen M, Virta LJ, Pokka T, Kroger L, Vahasalo P., Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections? J Rheumatol 2015; 42: 521-6.
83. Dethlefsen L, Relman DA., Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108 Suppl 1: 4554-61.
84. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, et al., Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488: 621-6.
85. Olle B., Medicines from microbiota. Nat Biotechnol 2013; 31: 309-15.
86. Van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al., Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-15.
87. Colman RJ, Rubin DT., Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 2014; 8: 1569-81.
88. Mazmanian SK, Round JL, Kasper DL., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620-5.
89. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al., Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337-41.
90. Lehman TJ, Allen JB, Plotz PH, Wilder RL., Lactobacillus casei cell wall-induced arthritis in rats: cell wall fragment distribution and persistence in chronic arthritis-susceptible LEW/N and -resistant F344/N rats. Arthritis Rheum 1984; 27: 939-42.
91. Amdekar S, Singh V, Singh R, Sharma P, Keshav P, Kumar A., Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. J Clin Immunol 2011; 31: 147-54.
92. Jenks K, Stebbings S, Burton J, Schultz M, Herbison P, Highton J., Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol 2010; 37: 2118-125.
93. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, et al., Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 2014; 17: 519-27.
94. Pineda M, Thompson SF, Summers K, de Leon F, Pope J, Reid G., A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit 2011; 17: CR347-54.
95. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, et al., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-73.
96. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446-50.
97. Wang Y, Telesford KM, Ochoa-Reparaz J, Haque-Begum S, Christy M, Kasper EJ, et al., An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun 2014; 5: 4432.
98. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB., Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132: 562-75.